Nuvasive Inc (NUVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | |
| Cash Flows From Operating Activities | |
| Net Income | -15,110 |
| Depreciation Amortization | 1,432 |
| Accounts receivable | -1,102 |
| Other Working Capital | -959 |
| Other Operating Activity | 1,741 |
| Operating Cash Flow | $-13,998 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,206 |
| Other Investing Activity | -757 |
| Investing Cash Flow | $-1,963 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -507 |
| Common Stock Issued | 12 |
| Other Financing Activity | 13,704 |
| Financing Cash Flow | $13,209 |
| Beginning Cash Position | 9,658 |
| End Cash Position | 6,906 |
| Net Cash Flow | $-2,752 |
| Free Cash Flow | |
| Operating Cash Flow | -13,998 |
| Capital Expenditure | -1,259 |
| Free Cash Flow | -15,257 |